Patients are always at the center of our work. We offer maximum care for adult patients suffering from hematological and oncological diseases. We work closely with other departments of the University Hospital Jena and with referring hospitals and physicians in private practice to provide patients with the best possible diagnostics and therapy. In our interdisciplinary tumor board we discuss individual therapy approaches. The entire department is subject to a strict quality management system and is certified in accordance to DIN EN ISO 9001:2008.
Prof. Andreas Hochhaus Director, Department of Hematology and Medical Oncology, Clinic for Internal Medicine II; Chair, University Tumor Center
Deutschlandweite Studie: Leukemie-Medikament Ruxolitinib auch bei Covid-19
For four days - from 19 to 22 February 2020 - scientists, health care professionals, students as well as politicians and government officials discussed the latest findings in cancer medicine. More than 10,000 participants took part in nearly 300 sessions. The German Cancer Congress (Deutscher Krebskongress, DKK) is the largest and most prominent German-speaking oncological congress. 2020 was the 34th anniversary of the DKK, a well-respected institution for everyone involved in the fight against cancer.
"It is essential that innovative therapies which have proven effective in practice become universally applicable medical standards as quickly as possible," said Congress President Prof. Andreas Hochhaus (Director of the Department of Hematology & Oncology, University Hospital Jena, Germany.)
José Carreras inaugurates leukemia unit at University Hospital Jena. José Carreras leukemia foundation promotes construction with one million euros.
Photo: Schacke (José Carreras visits the new stem cell transplant unit at University Hospital Jena in November 2017)